The number of people with susceptibility test result for rifampicin in South Sudan

South Sudan: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile

Latest (2021)
0
Change on year
down 100.0%
World rank
142nd
of 146 countries
All-time high
4.64
in 2017
All-time low
0
in 2021
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in South Sudan, 2017–2021

0123452017201920212017: 4.62018: 0.6382019: 0.1712020: 4.62021: 0

Source: World Health Organization, Global Health Observatory.

Analysis

In 2021, the number of people with susceptibility test result for rifampicin in South Sudan stood at 0. That is the lowest value across all 5 years on record.

The figure is down 100.0% on the previous year and down 100.0% over five years.

South Sudan ranks 142nd of 146 countries on this measure, in the bottom quarter.

The number of people with susceptibility test result for rifampicin in South Sudan, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. in South Sudan, 2017 to 2021.
Year Value Change
2017 4.64
2018 0.6381 -86.2%
2019 0.1707 -73.2%
2020 4.61 +2600.9%
2021 0 -100.0%

South Sudan compared with similar countries

  • South Sudan's 0 is below the median for low income countries, which is 37.16. (13 countries reporting)
  • South Sudan's 0 is below the median for Sub-Saharan Africa, which is 61.16. (32 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 1.82 0.1707 4.64 3
2020s 2.31 0 4.61 2

Countries ranked near South Sudan

  1. 139 Central African Republic 9.75 compare
  2. 140 Venezuela, Bolivarian Republic of 3.31 compare
  3. 141 France 1.45 compare
  4. 142 Grenada 0 compare
  5. 142 Sao Tome and Principe 0 compare
  6. 142 Vanuatu 0 compare
  7. 142 Mauritania 0 compare

See the full ranking of 148 places →

More health data for South Sudan

All data for South Sudan →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in South Sudan?
The number of people with susceptibility test result for rifampicin in South Sudan was 0 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in South Sudan?
The highest recorded value was 4.64 in 2017.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in South Sudan?
The lowest recorded value was 0 in 2021.
How does South Sudan rank for the number of people with susceptibility test result for rifampicin?
South Sudan ranks 142nd out of 146 countries with data for 2021.
Where does this South Sudan data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in South Sudan. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/south-sudan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/south-sudan/">The number of people with susceptibility test result for rifampicin in South Sudan</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed